These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum. Rivas F; Del Mármol C; Scalese G; Pérez-Díaz L; Machado I; Blacque O; Medeiros A; Comini M; Gambino D J Inorg Biochem; 2022 Dec; 237():112016. PubMed ID: 36244312 [TBL] [Abstract][Full Text] [Related]
5. Plant Terpenoids as Hit Compounds against Trypanosomiasis. Durão R; Ramalhete C; Madureira AM; Mendes E; Duarte N Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337138 [TBL] [Abstract][Full Text] [Related]
6. Plant-derived compounds in treatment of leishmaniasis. Oryan A Iran J Vet Res; 2015; 16(1):1-19. PubMed ID: 27175144 [TBL] [Abstract][Full Text] [Related]
7. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp. Scarim CB; Chelucci RC; Dos Santos JL; Chin CM Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962 [TBL] [Abstract][Full Text] [Related]
9. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives. Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823 [TBL] [Abstract][Full Text] [Related]
10. Naphthoquinones and Derivatives for Chemotherapy: Perspectives and Limitations of their Anti-trypanosomatids Activities. Dantas-Pereira L; Cunha-Junior EF; Andrade-Neto VV; Bower JF; Jardim GAM; da Silva Júnior EN; Torres-Santos EC; Menna-Barreto RFS Curr Pharm Des; 2021; 27(15):1807-1824. PubMed ID: 33167829 [TBL] [Abstract][Full Text] [Related]
11. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective. González M; Cerecetto H Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846 [TBL] [Abstract][Full Text] [Related]
12. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease. Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408 [TBL] [Abstract][Full Text] [Related]
13. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review. Benaim B; Garcia CR Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874 [TBL] [Abstract][Full Text] [Related]
14. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Lepesheva GI; Waterman MR Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513 [TBL] [Abstract][Full Text] [Related]
16. Overview of the role of kinetoplastid surface carbohydrates in infection and host cell invasion: prospects for therapeutic intervention. Valente M; Castillo-Acosta VM; Vidal AE; González-Pacanowska D Parasitology; 2019 Dec; 146(14):1743-1754. PubMed ID: 31603063 [TBL] [Abstract][Full Text] [Related]
18. Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery. Bhattacharya A; Corbeil A; do Monte-Neto RL; Fernandez-Prada C Genes (Basel); 2020 Jun; 11(7):. PubMed ID: 32610603 [TBL] [Abstract][Full Text] [Related]
19. Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure. Rodrigues JC; Godinho JL; de Souza W Subcell Biochem; 2014; 74():1-42. PubMed ID: 24264239 [TBL] [Abstract][Full Text] [Related]
20. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles. Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]